Daratumumab in Primary Antiphospholipid Syndrome
Clinical trial NCT05671757 · RECRUITING
Trial details
- NCT number
- NCT05671757
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-26
- Primary completion
- 2026-06-24
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.